Pioneering a New Era in Oral Cancer Treatment with Electrospun Nanofibers: A Comprehensive Insight
- PMID: 39773055
- DOI: 10.2174/0118715206348821241119100134
Pioneering a New Era in Oral Cancer Treatment with Electrospun Nanofibers: A Comprehensive Insight
Abstract
Oral cancer, currently ranked 16th among the most prevalent malignancies worldwide according to GLOBOCAN, presents significant challenges to global oral health. Conventional treatment modalities such as surgery, radiation, and chemotherapy often have limitations, prompting the need for innovative therapeutic approaches. Tissue engineering has emerged as a promising solution aimed at developing biocompatible, functional, and biologically responsive tissue constructs. This approach involves the integration of cells, bioactive compounds, and scaffolds to enhance treatment efficacy. Electrospun nanofibers, mimicking the extracellular matrix, exhibit considerable potential in addressing complex oral health issues by influencing cellular behavior. The versatility of electrospinning technology allows for the fabrication of fiber scaffolds with high surface area, making them ideal for localized delivery of bioactive compounds or pharmaceuticals. Enhancing these electrospun scaffolds with growth factors, nanoparticles, and biologically active substances significantly increases their therapeutic appeal in oral cancer management. This review offers a comprehensive examination of the various applications of electrospun nanofibers in oral cancer therapy. Utilizing electronic databases such as PubMed, CrossREF, and Google Scholar, we conducted an extensive review of relevant literature concerning "electrospun nanofibers" and their therapeutic potential in oral cancer treatment. Key topics addressed include engineering methodologies, drug diffusion mechanisms, factors influencing nanofiber scaffold design, toxicity concerns, and clinical implications. The findings underscore the transformative potential of electrospun nanofibers in revolutionizing oral cancer therapy.
Keywords: Oral cancer; drug delivery; electrospinning; nanofibers scaffolds; tissue engineering.; tissue regeneration.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Application and Development of Electrospun Nanofiber Scaffolds for Bone Tissue Engineering.ACS Biomater Sci Eng. 2024 Jul 8;10(7):4114-4144. doi: 10.1021/acsbiomaterials.4c00028. Epub 2024 Jun 3. ACS Biomater Sci Eng. 2024. PMID: 38830819 Review.
-
Electrospun nanofibers of collagen and chitosan for tissue engineering and drug delivery applications: A review.Int J Biol Macromol. 2025 Mar;296:139663. doi: 10.1016/j.ijbiomac.2025.139663. Epub 2025 Jan 8. Int J Biol Macromol. 2025. PMID: 39793786 Review.
-
Surface-functionalized electrospun nanofibers for tissue engineering and drug delivery.Adv Drug Deliv Rev. 2009 Oct 5;61(12):1033-42. doi: 10.1016/j.addr.2009.07.007. Epub 2009 Jul 27. Adv Drug Deliv Rev. 2009. PMID: 19643152
-
Cell-matrix mechanical interaction in electrospun polymeric scaffolds for tissue engineering: Implications for scaffold design and performance.Acta Biomater. 2017 Mar 1;50:41-55. doi: 10.1016/j.actbio.2016.12.034. Epub 2016 Dec 21. Acta Biomater. 2017. PMID: 28011142 Review.
-
Current approaches to electrospun nanofibers for tissue engineering.Biomed Mater. 2013 Feb;8(1):014102. doi: 10.1088/1748-6041/8/1/014102. Biomed Mater. 2013. PMID: 23472258
Cited by
-
Innovative Antimicrobial Nanofibers: Natural Integrations for Enhanced Wound Healing and Biofilm Disruption.AAPS PharmSciTech. 2025 Jul 1;26(6):181. doi: 10.1208/s12249-025-03178-5. AAPS PharmSciTech. 2025. PMID: 40593407
References
-
- Pandey P.; Arya D.K.; Deepak P.; Ali D.; Alarifi S.; Srivastava S.; Lavasanifar A.; Rajinikanth P.S.; αvβ3 integrin and folate-targeted pH-sensitive liposomes with dual ligand modification for metastatic breast cancer treatment. Bioengineering (Basel) 2024,11(8),800 - DOI
-
- Ferlay J.; Colombet M.; Soerjomataram I.; Parkin D.M.; Piñeros M.; Znaor A.; Bray F.; Cancer statistics for the year 2020: An overview. Int J Cancer 2021,149(4),778-789 - DOI
-
- Lavudi K.; Nuguri S.M.; Pandey P.; Kokkanti R.R.; Wang Q.E.; ALDH and cancer stem cells: Pathways, challenges, and future directions in targeted therapy. Life Sci 2024,356,123033 - DOI
-
- Pandey P.; Chaudhary R.; Tripathi D.; Lavudi K.; Dua K.; Weinfeld M.; Lavasanifar A.; Rajinikanth P.S.; Personalized treatment approach for HER2-positive metastatic breast cancer. Med Oncol 2024,41(11),252 - DOI
-
- Bizuayehu H.M.; Dadi A.F.; Hassen T.A.; Ketema D.B.; Ahmed K.Y.; Kassa Z.Y.; Amsalu E.; Kibret G.D.; Alemu A.A.; Alebel A.; Global burden of 34 cancers among women in 2020 and projections to 2040: Population‐based data from 185 countries/territories. Int J Cancer 2024,154(8),1377-93
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical